SEC Filing Summary: Form 6-K
Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV (a foreign private issuer), not Lakefront Biotherapeutics NV, for the month of October 2025. The filing, dated October 21, 2025, serves to incorporate by reference a press release (Exhibit 99.1) issued on the same date. The registrant files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing referencing an external press release rather than a financial statement.
Material Changes
No material financial changes or comparative period data are disclosed within the text of this Form 6-K. The filing solely announces the issuance of a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, or contingencies. It notes that quotes from Henry Gosebruch in the attached press release are excluded from incorporation by reference into certain Registration Statements on Form S-8.
Key Facts for Investor Verification
- Entity Discrepancy: The filing is for Galapagos NV, despite the request metadata referencing Lakefront Biotherapeutics NV.
- Content Source: All substantive information regarding the October 21, 2025 event is contained in the attached Exhibit 99.1 (Press Release), which is not included in the provided text.
- Financial Data: No financial metrics are present in this specific filing document.
- Exclusions: Specific quotes from Henry Gosebruch in the press release are explicitly excluded from incorporation into Form S-8 registration statements.